Valuation: C&R Research Inc.

Market Cap 2.22TCr 1.61Cr 1.38Cr 1.29Cr 1.18Cr 2.23Cr 154.04Cr 2.25Cr 15Cr 5.94Cr 77Cr 6.04Cr 5.91Cr 256.65Cr P/E 2024
17.1x
P/E 2025 19.9x
Enterprise Value 1.96TCr 1.41Cr 1.22Cr 1.13Cr 1.04Cr 1.96Cr 135.52Cr 1.98Cr 13Cr 5.23Cr 68Cr 5.31Cr 5.2Cr 225.79Cr EV / Sales 2024
0.98x
EV / Sales 2025 0.75x
Free-Float
36.73%
Yield 2024
0.86%
Yield 2025 -
1 day-0.87%
1 week-3.97%
Current month+9.51%
1 month-1.43%
3 months-39.25%
6 months-57.19%
Current year-57.00%
1 week 1,911
Extreme 1911
2,095
1 month 1,671
Extreme 1671
2,095
Current year 1,667
Extreme 1667
4,870
1 year 1,667
Extreme 1667
5,890
3 years 1,667
Extreme 1667
11,975
5 years 1,667
Extreme 1667
13,400
10 years 1,667
Extreme 1667
13,400
Manager TitleAgeSince
Chief Executive Officer 74 08/12/2021
Director of Finance/CFO 49 -
President 56 -
Director TitleAgeSince
Director/Board Member 74 08/12/2021
Director/Board Member 62 28/10/2021
Director/Board Member 56 -
Date Insider Type Main position Quantity % Market Cap.
22/12/24 Sell 73,163 0.1290%
23/09/24 Buy 6,675 0.0118%
23/09/24 Buy 13,325 0.0236%
Change 5-day change 1-year change 3-year change Capi.($)
-0.87%-3.97%-62.24%-71.23% 1.62Cr
-0.74%+4.48%+3.74%+22.46% 5.16TCr
+1.01%+3.86%+471.68%+577.49% 4.49TCr
+0.16%+9.96%+36.14%+20.40% 4.28TCr
-0.66%+7.05%+18.59%+83.42% 4.26TCr
+0.88%-3.48%+17.20%+57.20% 3.18TCr
-0.12%+7.18%+33.73%+148.24% 1.73TCr
-0.53%+1.39% - - 1.66TCr
+0.58%+4.00%+7.17%+30.59% 1.48TCr
+1.15%+6.62%+84.49%+47.81% 1.41TCr
Average +0.09%+4.07%+67.83%+101.82% 2.76TCr
Weighted average by Cap. +0.10%+5.13%+100.57%+142.47%

Financials

2024 2025
Net sales 5.97TCr 4.32Cr 3.71Cr 3.46Cr 3.17Cr 5.98Cr 413.4Cr 6.04Cr 41Cr 16Cr 207.48Cr 16Cr 16Cr 688.77Cr 6.5TCr 4.7Cr 4.04Cr 3.77Cr 3.45Cr 6.51Cr 450.06Cr 6.58Cr 45Cr 17Cr 225.88Cr 18Cr 17Cr 749.85Cr
Net income 383.86Cr 27.75L 23.84L 22.26L 20.38L 38.46L 27Cr 38.85L 2.64Cr 1.03Cr 13Cr 1.04Cr 1.02Cr 44Cr 258.55Cr 18.69L 16.06L 15L 13.73L 25.91L 18Cr 26.17L 1.78Cr 69.06L 8.99Cr 70.22L 68.7L 30Cr
Net Debt -767.36Cr -55.48L -47.65L -44.51L -40.75L -76.89L -53Cr -77.66L -5.27Cr -2.05Cr -27Cr -2.08Cr -2.04Cr -89Cr -267.4Cr -19.33L -16.61L -15.51L -14.2L -26.79L -19Cr -27.06L -1.84Cr -71.42L -9.3Cr -72.63L -71.05L -31Cr
Logo C&R Research Inc.
C&R Research Inc is a Korea-based company is mainly engaged in the clinical trial agency and drug development business. The Company is mainly engaged in the provision of comprehensive early-stage clinical services in the areas of medical writing, regulatory matters, data management, biostatistics and others. The Company is mainly engaged in the provision of consulting services including initial clinical development, clinical trial development, global clinical trial development and others. In addition, the Company is also engaged in the operation of clinical trial training center.
Employees
510
Date Price Change Volume
24/26/24 ₩1,935.00 -0.87% 5,694
21/26/21 ₩1,952.00 -1.46% 6,459
20/26/20 ₩1,981.00 -0.40% 4,473
19/26/19 ₩1,989.00 -0.05% 6,689
  1. Stock Market
  2. Stocks
  3. A359090 Stock